Jarrow Formulas, Women’s Fem Dophilus, 60 Veggie Caps
| Supplement Facts | ||
| Serving Size: 1 Capsule | ||
| Servings Per Container: 60 | ||
| Amount Per Serving | % DV | |
| Proprietary Probiotic Blend Lacticaseibacillus rhamnosus, GR-1 Limosilactobacillus reuteri, RC-14 | 134 mg (1 Billion CFUsxa7) | |
| xa7Minimum 1 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date. Daily Value (DV) not established. | ||
Description
- Vaginal/Urinary Tract Health
- No Refrigeration Necessary
- 25+ Years of Research/Clinical Studies**
- Free of Major Allergens
- Suitable for Vegetarians/Vegans
- Oral Probiotic Supplement
- Gluten Free
- Vegan
- Veggie Cap
GR-1/RC-14 and Vaginal Flora (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
Fem-Dophilus contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus, GR-1xa1 and Limosilactobacillus reuteri, RC-14xa1, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.
Strains Matter
Jarrow Formulas’ Probiotics Contain Clinically Documented Strains
Box contains smaller, Activ-Vial moisture-controlled desiccant bottle for better stability of probiotic bacteria.
xa1Updates based on official taxonomy reclassification.
**25+ Years of GR-1/RC-14 Research / Clinical Studies.
Reviews
There are no reviews yet.